DNA is responsible for European junk food addictions

By Admin
Share
Scientists have discovered that people living in Europe feel more attracted to eating junk food and drinking alcohol than people who live in Eastern pa...

Scientists have discovered that people living in Europe feel more attracted to eating junk food and drinking alcohol than people who live in Eastern parts of the world.

DNA analysis has found that Westerners may have evolved to be more inclined to make such dietary choices, after having to survive cold winters by consuming calorific foods and drinks.

Research showed that Europeans were more likely to have strong genes which control a ‘switch’ within the body that works to regulate appetites.

Meanwhile, the study found that people of Asian descent had weaker genetic switches, suggesting they are less likely to choose to consume junk food.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

The investigation was carried out by scientists at the University of Aberdeen and the results have been published in the Journal of Neuropsychopharmocology.

“The switch controls the areas of the brain which allows us to select which foods we would like to eat and if it is turned on too strongly we are more likely to crave fatty foods and alcohol,” said Dr Alasdair MacKenzie, who led the study.

“The fact that the weaker switch is found more frequently in Asians compared to Europeans suggests they are less inclined to select such options.”

MacKenzie added: “A preference for food with a higher fat and alcohol content would have been important for survival.

“The negative effects of fat and alcohol we see today would not have mattered so much then as life expectancies were between 30 and 40 years.”

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma